vTv Therapeutics Inc expected to post a loss of 9  cents a share - Earnings Preview

vTv Therapeutics

30/07/2022 24:34

* vTv Therapeutics Inc  VTVT.OQ   VTVT.O  is expected
to show a
fall in quarterly revenue when it reports  results on August 2
(estimated). 
    * ​Refinitiv's mean analyst estimate for vTv Therapeutics
Inc is
for a loss of 9 cents per share. For the same quarter last year,
the company reported a loss of 1 cent per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for vTv
Therapeutics
Inc is $5​, above​ its last closing price of $0.90. ​​​

This summary was machine generated July 29 at 23:34 GMT.  All
figures in US dollars  unless otherwise stated